These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20481263)

  • 1. The tolerability and efficacy of levetiracetam.
    Tellez-Zenteno JF
    Can J Neurol Sci; 2010 May; 37(3):309. PubMed ID: 20481263
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and tolerability of levetiracetam in children with epilepsy.
    Li J; Xiao N; Chen S
    Brain Dev; 2011 Feb; 33(2):145-51. PubMed ID: 20359839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levetiracetam in the management of epilepsy.
    Leach JP
    Hosp Med; 2004 Dec; 65(12):740-4. PubMed ID: 15624450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levetiracetam in pediatrics.
    Vigevano F
    J Child Neurol; 2005 Feb; 20(2):87-93. PubMed ID: 15794171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conclusions of the available meta-analyses exploring the efficacy of levetiracetam.
    Tellez-Zenteno JF
    Can J Neurol Sci; 2011 May; 38(3):388-9. PubMed ID: 21515492
    [No Abstract]   [Full Text] [Related]  

  • 6. Levetiracetam monotherapy during pregnancy: a case series.
    Long L
    Epilepsy Behav; 2003 Aug; 4(4):447-8. PubMed ID: 12899868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Levetiracetam (keppra) in epileptology].
    Kalinin VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(3):74-7. PubMed ID: 18683359
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of levetiracetam in children with epilepsy younger than 2 years of age.
    Krief P; Li Kan ; Maytal J
    J Child Neurol; 2008 May; 23(5):582-4. PubMed ID: 18448575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experience with levetiracetam in childhood epilepsy].
    Neuwirth M; Saracz J; Hegyi M; Paraicz E; Kollár K; Móser J; Rosdy B; Herczegfalvi A; Fogarasi A
    Ideggyogy Sz; 2006 May; 59(5-6):179-82. PubMed ID: 16786712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of levetiracetam for pediatric refractory epilepsy.
    Muramatsu K; Sawaura N; Ogata T; Makioka N; Tomita K; Motojima T; Ida K; Hazama K; Arakawa H
    Brain Dev; 2017 Mar; 39(3):231-235. PubMed ID: 27745925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The place of levetiracetam in the treatment of epilepsy.
    Leppik IE
    Epilepsia; 2001; 42 Suppl 4():44-5. PubMed ID: 11564126
    [No Abstract]   [Full Text] [Related]  

  • 12. Spritam--a new formulation of levetiracetam for epilepsy.
    Med Lett Drugs Ther; 2016 Jun; 58(1497):78-9. PubMed ID: 27305068
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of levetiracetam as an add-on therapy in children aged less than 4 years with refractory epilepsy.
    Li S; Cao J; Xiao N; Cai F
    J Child Neurol; 2010 May; 25(5):609-13. PubMed ID: 19779208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy.
    Betts T; Waegemans T; Crawford P
    Seizure; 2000 Mar; 9(2):80-7. PubMed ID: 10845730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of levetiracetam: an add-on trial in children with refractory epilepsy.
    Grosso S; Franzoni E; Coppola G; Iannetti P; Verrotti A; Cordelli DM; Marchiani V; Pascotto A; Spalice A; Acampora B; Morgese G; Balestri P
    Seizure; 2005 Jun; 14(4):248-53. PubMed ID: 15911359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy, tolerability and safety of levetiracetam therapy in a pediatric population.
    Tekgül H; Gencpinar P; Çavuşoğlu D; Dündar NO
    Seizure; 2016 Mar; 36():16-21. PubMed ID: 26874856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective study of the use of levetiracetam in childhood seizure disorders.
    Koukkari MW; Guarino EJ
    J Child Neurol; 2004 Dec; 19(12):944-7. PubMed ID: 15704867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term experience with levetiracetam.
    Abou-Khalil B; Lazenby B
    Epileptic Disord; 2003 May; 5 Suppl 1():S33-7. PubMed ID: 12915339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term continuation of levetiracetam in patients with refractory epilepsy.
    Krakow K; Walker M; Otoul C; Sander JW
    Neurology; 2001 Jun; 56(12):1772-4. PubMed ID: 11425954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The possibilities of using keppra (levetiracetam) in different neurological diseases].
    Lebedeva AV; Nemenov DG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; Suppl 2():49-56. PubMed ID: 19431251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.